Abstract:The combination of point-of-care (POC) medical microdevices and machine learning has the potential transform the practice of medicine. In this area, scalable lab-on-a-chip (LOC) devices have many advantages over standard laboratory methods, including faster analysis, reduced cost, lower power consumption, and higher levels of integration and automation. Despite significant advances in LOC technologies over the years, several remaining obstacles are preventing clinical implementation and market penetration of these novel medical microdevices. Similarly, while machine learning has seen explosive growth in recent years and promises to shift the practice of medicine toward data-intensive and evidence-based decision making, its uptake has been hindered due to the lack of integration between clinical measurements and disease determinations. In this Account, we describe recent developments in the programmable bio-nanochip (p-BNC) system, a biosensor platform with the capacity for learning. The p-BNC is a "platform to digitize biology" in which small quantities of patient sample generate immunofluorescent signal on agarose bead sensors that is optically extracted and converted to antigen concentrations. The platform comprises disposable microfluidic cartridges, a portable analyzer, automated data analysis software, and intuitive mobile health interfaces. The single-use cartridges are fully integrated, self-contained microfluidic devices containing aqueous buffers conveniently embedded for POC use. A novel fluid delivery method was developed to provide accurate and repeatable flow rates via actuation of the cartridge's blister packs. A portable analyzer instrument was designed to integrate fluid delivery, optical detection, image analysis, and user interface, representing a universal system for acquiring, processing, and managing clinical data while overcoming many of the challenges facing the widespread clinical adoption of LOC technologies. We demonstrate the p-BNC's flexibility through the completion of multiplex assays within the single-use disposable cartridges for three clinical applications: prostate cancer, ovarian cancer, and acute myocardial infarction. Toward the goal of creating "sensors that learn", we have developed and describe here the Cardiac ScoreCard, a clinical decision support system for a spectrum of cardiovascular disease. The Cardiac ScoreCard approach comprises a comprehensive biomarker panel and risk factor information in a predictive model capable of assessing early risk and late-stage disease progression for heart attack and heart failure patients. These marker-driven tests have the potential to radically reduce costs, decrease wait times, and introduce new options for patients needing regular health monitoring. Further, these efforts demonstrate the clinical utility of fusing data from information-rich biomarkers and the Internet of Things (IoT) using predictive analytics to generate single-index assessments for wellness/illness status. By promoting disease prevention and personalized wellness management, tools of this nature have the potential to improve health care exponentially.

Machine-Learning-Assisted Blood Parameter Sensing Platform for Rapid Next Generation Biomedical and Healthcare Applications

Engineering a Universal and Fully Automatic Analyzer for Multichannel and On-Site Biochemical Detection in Body Fluids

Rapid point-of-care Hemoglobin measurement through low-cost optics and Convolutional Neural Network based validation

Development of a Portable and Sensitive Blood Serum Test System Using LED-based Absorption Photometry and Pump-Free Microfluidic Technology

Machine Learning Sensors for Diagnosis of COVID-19 Disease Using Routine Blood Values for Internet of Things Application

Development of a point-of-care colorimetric metabolomic sensor platform

Programmable Bio-nanochip Platform: A Point-of-Care Biosensor System with the Capacity To Learn

Electro-Optical Multiclassification Platform for Minimizing Occasional Inaccuracy in Point-of-Care Biomarker Detection

Enhanced Sensitivity for Quantifying Disease Markers via Raman and Machine-Learning of Circulating Biofluids in Optofluidic Chips

A Microfluidic Platform With Digital Readout And Ultra-Low Detection Limit For Quantitative Point-Of-Care Diagnostics

An Automatic Whole Blood Analyzer for Renal Function Analysis with a Centrifugal Microfluidic Device

Integrated Platform Addressing the Finger-Prick Blood Processing Challenges of Point-of-Care Electrical Biomarker Testing

Multiparameter mobile blood analysis for complete blood count using contrast-enhanced defocusing imaging and machine vision

AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring

A Sample-to-answer Quantitative Platform for Point-of-care Testing of Biochemical Markers in Whole Blood

An AI-assisted microfluidic paper-based multiplexed surface-enhanced Raman scattering (SERS) biosensor with electrophoretic removal and electrical modulation for accurate acute myocardial infarction (AMI) diagnosis and prognosis

DiabiTech- Non-Invasive Blood Glucose Monitoring System

Implementation of Non-Invasive Blood Glucose Monitoring System

High Throughput Blood Analysis Based on Deep Learning Algorithm and Self‐Positioning Super‐Hydrophobic SERS Platform for Non‐Invasive Multi‐Disease Screening

Non-invasive Detection of Haemoglobin, Platelets, and Total Bilirubin Using Hyperspectral Cameras.

A smartphone-connected point-of-care photochemical biosensor for the determination of whole blood creatinine by differential optical signal readout